Table 9.
Analysis by Neurosurgical Training Year
| Junior Resident (PGY 1–3) | Senior Resident (PGY 4–5) | P | |
|---|---|---|---|
| Neurosurgery training country | |||
| Mexico | 73 (42) | 34 (26.8) | 0.019∗ |
| Other country | 101 (58) | 85 (71,4) | |
| Hospital type | |||
| Exclusive hospital for neurologic diseases | 11 (6.3) | 7 (5.9) | 0.015∗ |
| Medical specialty hospital | 95 (54.6) | 43 (36.1) | |
| General hospital | 67 (38.5) | 68 (57.1) | |
| Others | 1 (0.6) | 1 (0.8) | |
| Strategies to reduce resident exposure to COVID-19: | 98 (56.3) | 52 (43.7) | 0.049∗ |
| Reduction of the number of workdays per week | |||
| Your hospital asks you to treat patients with COVID | 143 (82.2) | 79 (66.4) | 0.002∗ |
| ICU COVID | 48 (27.6) | 35 (29.4) | 0.733 |
| Medical care area | 100 (57.5) | 46 (38.7) | 0.002∗ |
| Mechanical ventilators in patients with COVID | 12 (6.9) | 17 (14.3) | 0.038∗ |
| Emergency area coverage | 64 (36.8) | 29 (24.4) | 0.025∗ |
| Neurologic surgeries | 104 (59.8) | 87 (73.1) | 0.019∗ |
| Positive polymerase chain reaction COVID-19 test result | 35 (20.1) | 28 (23.5) | 0.793 |
| Respiratory disease that warrants hospitalization | 2 (1.1) | 3 (2.5) | 0.373 |
| Respiratory disease that warrants management in the ICU | 0 (0) | 2 (1.7) | 0.086 |
PGY, postgraduate year; ICU, intensive care unit.
∗
Statistically significant variables P < 0.05 obtained by the χ2 test.